Bpifrance is a financial institution dedicated to supporting companies throughout their development stages, particularly those preparing for stock market listing and seeking credit equity. The organization provides a range of financial solutions, including financing, innovation assistance, and capital investment. By integrating various entities such as OSEO and CDC Entreprises, Bpifrance aims to deliver tailored financial support that addresses the specific needs of businesses. The institution is committed to fostering innovation and helping companies transition toward sustainable growth, ensuring they are well-equipped to face future challenges.
Director of Transverse Venture Capital Investments Division
Benoit Barteau Ph.D
Investment Director
Nicolas Berdou
Investment Director, Defense Expert
Clarisse Blandin
Investment Director
Elyssa Maufras du Châtellier
Investment Director
Edouard Combette
Investment Director
Charlotte Corbaz
Investment Drector - Large Venture
Sofia Dahoune
Associate
Nicolas Dardenne
Senior Investment Director, Normandy (Caen Rouen)
Arnaud Despoisse
Director of Occitanie Participations
Nicolas Dufourcq
CEO
Mailys Ferrere
Director of Large Venture Investments
Romain Fourcade
Investment Director
Paul-Francois Fournier
Executive Director, Innovation Department
Vanessa Giraud
Director of Environmental Impact Funds
Alessandro Gonella
Director
Gwenael Hamon
Investment Director
Laurent Higueret
Senior Investment Director, Healthcare and Life Sciences - Large Venture Fund
Veronique Jacq
Head of Digital Venture team
Louis Janneau
Investment Director and Fund Manager
Magali Joessel
Director of Funds
So-Yeon Koo
Senior Investment Manager
Jérôme Langlade
Investment Director Aquitaine / Limousin / Poitou-Charentes
Eric Lefebvre
Director
Stephane Lefevre-Sauli
Senior Investment Director
Arnaud Legardeur
Investment Director
Olivier Martinez
Investment Director
Serge Mesguich
Director of FIT
Louis Molis
Investment Director
Jean-Francois Morin
Investment Director
Sébastien Moynot
Director
Adrien Muller
Investment Director
Adrien Neel
Investment Director
Axel Piriou
Director of Investments
Olivier Rameil
Senior Investment Director / VC seed
Vincent Roque
Director
Thibaut Roulon Ph.D
Investment Director
Gilles Schang
Deputy Managing Director
Bruno Villeneuve
Associate
Jean-Marie Fougeray
Senior Investment Director, Brittany
Laure Michel
Investment Director
Past deals in Personal Health
Fizimed
Venture Round in 2025
Fizimed SAS, founded in 2017 and based in Strasbourg, France, specializes in manufacturing a perineal device designed to address urinary incontinence in women through pelvic floor reeducation. The company's flagship product, EMY, is a perineal probe that connects to a mobile app, allowing users to engage in personalized exercises for strengthening pelvic floor muscles. EMY not only captures real-time muscle contractions but also incorporates interactive elements, such as games, to motivate users during their five-minute workouts. Fizimed emphasizes user-friendliness and safety in its product design, aiming to empower women in managing their pelvic health at home. Additionally, the company actively seeks to eliminate the stigma surrounding urinary incontinence, fostering a supportive community on social media where women can share experiences and innovations related to this common health issue. Through its combination of medical efficacy and engaging technology, Fizimed aims to provide women with the tools they need to regain control over their pelvic health in a discreet and enjoyable manner.
Metyos
Pre Seed Round in 2024
Metyos is a Paris-based company specializing in wearable biosensor technology that monitors the effects of daily activities on nutrition and metabolism. By analyzing individual data, such as fat levels and energy metabolism dynamics, Metyos provides users with personalized fitness and nutrition plans. Their aim is to help individuals understand how their bodies respond to various actions, enabling them to make informed choices and effectively work towards their weight goals. Through this innovative approach, Metyos empowers users to regain control over their health and wellness.
Teale
Series A in 2023
Teale is a digital mental health platform that integrates psychology and technology to enhance mental well-being. The platform offers personalized and interactive digital healthcare solutions, enabling individuals to manage their mental health effectively. Teale also conducts collective workshops tailored to specific needs within workplaces, fostering a supportive environment for mental health initiatives. Through its curated network of mental health experts, Teale provides individual support and personalized digital programs, allowing users to monitor and improve their psychological resilience. This approach not only benefits individuals but also contributes to sustainable growth for organizations.
Lola Health
Pre Seed Round in 2022
Lola Health is an insurance technology firm that provides personalized health coverage tailored to the needs of its clients' businesses. The company focuses on enhancing employee well-being by offering support for various health issues, including female health, alternative medicine, and mental health. Lola Health's services include Angel Plus, an advisory platform that assists employees in navigating their health care options, as well as telecommunications and psychological support. By modernizing traditional insurance models, Lola Health aims to offer comprehensive coverage that includes assistance for care pathways like endometriosis, parenthood, and postpartum depression. This approach not only helps businesses attract and retain talent but also promotes overall employee performance and wellness.
Cuure
Series A in 2022
Cuure specializes in providing personalized vitamins and supplements tailored to individual health requirements. Utilizing data from health questionnaires and DNA tests, Cuure develops customized supplement plans aimed at enhancing overall health and wellness. Their offerings combine scientific research with a personalized approach, ensuring that users receive recommendations aligned with their specific health goals and body chemistry. Additionally, the platform promotes wellness habits through a tracking application, allowing individuals to monitor their supplement intake and adapt their health practices effectively. Cuure's commitment to fair pricing and personalized solutions makes it a distinctive player in the wellness industry.
Susu
Debt Financing in 2022
Susu is a dynamic and innovative company that offers a wide range of health services for families in the African diaspora. Susu provides a complete offer on Preventive care, Medical treatments, Management of chronic diseases, and Authentic drugs.
Susu
Grant in 2022
Susu is a dynamic and innovative company that offers a wide range of health services for families in the African diaspora. Susu provides a complete offer on Preventive care, Medical treatments, Management of chronic diseases, and Authentic drugs.
WhatMatters
Seed Round in 2022
WhatMatters offers cosmetics geared for home and hygiene care. They sell items including toothpaste, shower gel, hand sanitizer, cleansing water, dish soap, laundry detergent, and more. They provide a range of products for children as well.
Heroic sante
Seed Round in 2022
Heroic Sante is a virtual platform. They offer patients the chance to have their questions answered by qualified carers and learn from other patients. Their community works to create useful projects for patients and finances them thanks to statements on applications.
Omini
Seed Round in 2021
Omini is a French company, established in 2019 and based in Saint Mandé, that specializes in the development of portable and multipurpose bio-sensing devices for blood testing. The company’s biosensor platform allows for the simultaneous detection of multiple biomarkers, providing personalized blood biomarker data that can be utilized to tailor therapies and prevent acute crises in patients with chronic conditions. By employing advanced multiplex electrochemical biosensor technology, Omini's devices offer accurate and affordable solutions for identifying, analyzing, and monitoring various target biomarkers. This innovation supports decentralized testing and at-home monitoring, ultimately aiming to alleviate the burden on healthcare systems and improve patient outcomes. Omini primarily serves general practitioners, enhancing their ability to manage patient care effectively.
Fysali
Grant in 2021
Fysali breaks the taboo by providing remote, non-invasive bladder monitoring. They offer superior clinical accuracy, an exceptional patient experience, and a lower cost of care. They offer remote and noninvasive bladder monitoring services.
Kwit
Series A in 2021
Kwit is a developer of a mobile application focused on smoking cessation. The application employs evidence-based methods and principles derived from cognitive and behavioral therapy to assist users in their journey to quit smoking. By providing daily support infused with positivity and kindness, Kwit aims to guide individuals toward a smoke-free life, ultimately promoting healthier and happier lifestyles.
Medaviz
Series A in 2020
Medaviz is an online platform founded in 2014 and headquartered in Paris, France, that facilitates immediate communication between patients and healthcare professionals. The service allows users to connect with various specialists, including general practitioners, pediatricians, gynecologists, and psychologists, at any time. By providing access to medical advice around the clock, Medaviz enables users to address their medical issues or emergencies efficiently, enhancing the convenience of healthcare access.
Withings
Series B in 2020
Withings is a developer of digital health and wellness smart devices. The company makes a range of products that empower people to make the right decisions for their health. Its digital health and wellness smart devices include a fitness watch that enables users to measure their heart rate.
Exeliom
Grant in 2019
Exeliom is a clinical-stage biopharmaceutical company based in Dijon, France, focused on developing innovative microbial therapies that utilize commensal bacteria as therapeutic agents. Founded in 2016, Exeliom aims to unlock the therapeutic potential of gut microbiota to enhance health and longevity. The company specializes in creating a new class of medicines known as Live Biotherapeutics, which are designed to deliver microbiome-based immunotherapy for conditions such as inflammatory bowel diseases and cancer, with an initial focus on Crohn's Disease. By harnessing the role of microbiota in the immune system, Exeliom strives to provide patients with advanced treatments that improve their quality of life.
Microphyt
Venture Round in 2019
Microphyt specializes in the research, development, production, and marketing of natural algae-based products aimed at enhancing health and wellness. The company focuses on creating bioactive dietary supplements that support weight loss and brain health. Utilizing an industrial-scale supply of microalgae biomass and extracts, Microphyt ensures the preservation of cell integrity while producing commercial quantities of slow-growing or biofilm-forming species. This approach enables the healthcare industry to effectively meet the demands of personal care and food products, positioning Microphyt as a key player in the market for natural health solutions.
BioSerenity
Series B in 2019
BioSerenity is a company focused on enhancing the understanding and treatment of epilepsy and other chronic diseases through the development of digitally connected devices. These devices facilitate the retrieval and interpretation of electrophysiological signals, including electroencephalograms, electrocardiograms, and polysomnography. By enabling remote monitoring of continuous electrophysiological signals, BioSerenity aims to optimize patient care pathways in cardiology, neurology, and sleep disorders. The data collected from these devices, once anonymized, will be made available to researchers at the Institut du Cerveau et de la Moelle épinière, contributing to advancements in epilepsy research and improving diagnostic methods for the future.
Doctoconsult
Venture Round in 2018
Doctoconsult provides online heath care consultation services. E-Mental health startup. First video consultation service dedicated to psychiatrists and their patients in France. Today launching an innovated app co-designed by KOL physicians & researchers to help patients suffering from mental disorders.
Fizimed
Seed Round in 2018
Fizimed SAS, founded in 2017 and based in Strasbourg, France, specializes in manufacturing a perineal device designed to address urinary incontinence in women through pelvic floor reeducation. The company's flagship product, EMY, is a perineal probe that connects to a mobile app, allowing users to engage in personalized exercises for strengthening pelvic floor muscles. EMY not only captures real-time muscle contractions but also incorporates interactive elements, such as games, to motivate users during their five-minute workouts. Fizimed emphasizes user-friendliness and safety in its product design, aiming to empower women in managing their pelvic health at home. Additionally, the company actively seeks to eliminate the stigma surrounding urinary incontinence, fostering a supportive community on social media where women can share experiences and innovations related to this common health issue. Through its combination of medical efficacy and engaging technology, Fizimed aims to provide women with the tools they need to regain control over their pelvic health in a discreet and enjoyable manner.
BioSerenity
Series A in 2017
BioSerenity is a company focused on enhancing the understanding and treatment of epilepsy and other chronic diseases through the development of digitally connected devices. These devices facilitate the retrieval and interpretation of electrophysiological signals, including electroencephalograms, electrocardiograms, and polysomnography. By enabling remote monitoring of continuous electrophysiological signals, BioSerenity aims to optimize patient care pathways in cardiology, neurology, and sleep disorders. The data collected from these devices, once anonymized, will be made available to researchers at the Institut du Cerveau et de la Moelle épinière, contributing to advancements in epilepsy research and improving diagnostic methods for the future.
Withings
Series B in 2013
Withings is a developer of digital health and wellness smart devices. The company makes a range of products that empower people to make the right decisions for their health. Its digital health and wellness smart devices include a fitness watch that enables users to measure their heart rate.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.